We are live on ! Find out more
ENZN

ENZON PHARMACEUTICALS INC
ENZN

Delisted

ENZN was delisted on the 19th of May, 2016.

Back to rankings

1 hedge funds and large institutions have $16K invested in ENZON PHARMACEUTICALS INC in 2018 Q3 according to their latest regulatory filings, with funds opening new positions, 1 increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

60% more capital invested

Capital invested by funds: $10K → $16K (+$6K)

0% more funds holding

Funds holding: 1 → 1 (0)

Holders
1
Holders Change
–
Holders Change %
0%
% of All Funds
0.02%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
1
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
PAM
Panagora Asset Management
Massachusetts
+$6.22K

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
PAM
1
Panagora Asset Management
Massachusetts
$16K +$6.22K +25,232 +64%

ENZN Hedge Fund Activity: Q3 2018 in Review

1 of the 4,374 institutional investors tracked by Wall St. Rank reported a position in ENZON PHARMACEUTICALS INC (ENZN) for Q3 2018, worth a combined $16K — up 60% from $10K a quarter earlier.

Fund positioning in ENZN was balanced in Q3 2018: 0 funds opened new positions, 0 closed out, 1 added to existing stakes and 0 trimmed.

The largest buyer was Panagora Asset Management, adding an estimated $6.22K.

  • 1 institutional investor held ENZON PHARMACEUTICALS INC (ENZN) as of Q3 2018, unchanged from Q2 2018.
  • Funds reported $16K of ENZON PHARMACEUTICALS INC stock for Q3 2018, up 60% quarter-over-quarter.
  • 0 funds opened new ENZON PHARMACEUTICALS INC positions in Q3 2018 and 0 closed out.
  • The largest ENZON PHARMACEUTICALS INC buyer in Q3 2018 was Panagora Asset Management, an estimated $6.22K added.

Based on aggregated 13F filings for Q3 2018.